PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 4/17
Copy link
Facebook
Email
Notes
More

Market Analysis and Trades for 4/17

PharmD_KS's avatar
PharmD_KS
Apr 16, 2025
∙ Paid
16

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 4/17
Copy link
Facebook
Email
Notes
More
1
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so there is no reason to subscribe to both.

The weekly post and for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

SPY 0.00%↑

After the key weekly 5474-5480 spot was effectively capped to begin the week, the loss of 5444 yesterday after noon led to some weakness into the close and we of course got the NVDA 0.00%↑ news after hours. We opened on a true gap down (below the prior day’s low) and this set up the potential for a double distribution week to the downside. In this case the low 5400s was likely to be the upper edge with 5340 as the lower edge.

Buyers held 5346 in the morning, rallied to 5401 and then sold off into JPOW and nearly another 100 handles thereafter hitting a last reasonable target at our 5251.5-5260 spot. From the morning update:

Damage has been done to this weekly profile. While there are technical reasons why an “internal” higher low could form here, there is a significant amount of repair that will be required. Given JPOW effectively said “there is no fed put” I would argue that bulls are under significant pressure here.

Paid Content Below

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More